Mechanisms of current therapies for diabetes mellitus type 2
about
Adenosine monophosphate-activated protein kinase-based classification of diabetes pharmacotherapyMicroparticulate and nanoparticulate drug delivery systems for metformin hydrochloride.Weight Management in Patients with Type 1 Diabetes and Obesity.Synthesis of a New Zinc-Mixed Ligand Complex and Evaluation of Its Antidiabetic Properties in High Fat Diet: Low Dose Streptozotocin Induced Diabetic Rats.
P2860
Mechanisms of current therapies for diabetes mellitus type 2
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mechanisms of current therapies for diabetes mellitus type 2
@en
Mechanisms of current therapies for diabetes mellitus type 2.
@nl
type
label
Mechanisms of current therapies for diabetes mellitus type 2
@en
Mechanisms of current therapies for diabetes mellitus type 2.
@nl
prefLabel
Mechanisms of current therapies for diabetes mellitus type 2
@en
Mechanisms of current therapies for diabetes mellitus type 2.
@nl
P2860
P356
P1476
Mechanisms of current therapies for diabetes mellitus type 2
@en
P2093
Peter M Thulé
P2860
P304
P356
10.1152/ADVAN.00094.2012
P577
2012-12-01T00:00:00Z